Alnylam Pharmaceuticals Inc. (ALNY): Price and Financial Metrics
ALNY Price/Volume Stats
| Current price | $308.00 | 52-week high | $308.93 |
| Prev. close | $305.31 | 52-week low | $147.25 |
| Day low | $300.75 | Volume | 762,000 |
| Day high | $308.53 | Avg. volume | 907,587 |
| 50-day MA | $264.99 | Dividend yield | N/A |
| 200-day MA | $262.49 | Market Cap | 40.16B |
ALNY Stock Price Chart Interactive Chart >
Alnylam Pharmaceuticals Inc. (ALNY) Company Bio
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics[3] for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.[4] In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. (Source:Wikipedia)
ALNY Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ALNY Price Returns
| 1-mo | 11.37% |
| 3-mo | 25.96% |
| 6-mo | 20.19% |
| 1-year | 106.30% |
| 3-year | 129.83% |
| 5-year | 141.40% |
| YTD | 30.89% |
| 2024 | 22.94% |
| 2023 | -19.46% |
| 2022 | 40.14% |
| 2021 | 30.48% |
| 2020 | 12.85% |